MEDIMMUNE LIMITED
Other research and experimental development on natural sciences and engineering
MEDIMMUNE LIMITED
Other research and experimental development on natural sciences and engineering
Previous Company Names
Contact & Details
Contact
Registered Address
1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom
Full company profile for MEDIMMUNE LIMITED (02451177), an active company based in Cambridge, United Kingdom. Incorporated 11 Dec 1989. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2014–2024)
Cash in Bank
N/A
Net Assets
-£547.00M
Total Liabilities
£3060.00M
Turnover
£2595.00M
Employees
202
Debt Ratio
122%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 68 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Cambridge Antibody Technology Group Limited
United Kingdom
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Group Structure
Group Structure
Charges
Charges
Properties
Properties
| Address | Tenure | Price Paid | Date Added |
|---|---|---|---|
Suite 13, The Queen Mary Bioenterprises Innovation Centre, 42 New Road, London (E1 2AX) TOWER HAMLETS | Leasehold | - | 16 Jun 2022 |
Suite 11a, The Queen Mary Bioenterprises Innovation Centre, 42 New Road, London (E1 2AX) TOWER HAMLETS | Leasehold | - | 16 Jun 2022 |
Suite 3, The Queen Mary Bioenterprises Innovation Centre, 42 New Road, London (E1 2AX) TOWER HAMLETS | Leasehold | - | 16 Jun 2022 |
Suite 2, The Queen Mary Bioenterprises Innovation Centre, 42 New Road, London (E1 2AX) TOWER HAMLETS | Leasehold | - | 16 Jun 2022 |
Suite 9, The Queen Mary Bioenterprises Innovation Centre, 42 New Road, London (E1 2AX) TOWER HAMLETS | Leasehold | - | 16 Jun 2022 |
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 9 Feb 2026 | Officers | Termination of Pablo Panella as director on 1 Feb 2026 | |
| 19 Dec 2025 | Confirmation Statement | Confirmation statement made on 11 Dec 2025 with updates | |
| 7 Aug 2025 | Accounts | Annual accounts made up to 31 Dec 2024 | |
| 2 May 2025 | Officers | Appointment of Hannah Victoria Tattersall as director on 1 May 2025 | |
| 1 May 2025 | Officers | Termination of Adrian Charles Noel Kemp as director on 1 May 2025 |
Termination of Pablo Panella as director on 1 Feb 2026
Confirmation statement made on 11 Dec 2025 with updates
Annual accounts made up to 31 Dec 2024
Appointment of Hannah Victoria Tattersall as director on 1 May 2025
Termination of Adrian Charles Noel Kemp as director on 1 May 2025
Recent Activity
Latest Activity
Termination of Pablo Panella as director on 1 Feb 2026
2 months ago on 9 Feb 2026
Confirmation statement made on 11 Dec 2025 with updates
4 months ago on 19 Dec 2025
Annual accounts made up to 31 Dec 2024
8 months ago on 7 Aug 2025
Appointment of Hannah Victoria Tattersall as director on 1 May 2025
12 months ago on 2 May 2025
Termination of Adrian Charles Noel Kemp as director on 1 May 2025
12 months ago on 1 May 2025